Jon Walsh, founder, chief scientific officer, Unlearn, explains how regulators are clarifying best practices for integrating AI and digital twins into clinical research.

QNRX READ THE FULL QNRX RESEARCH REPORT FDA clears initiation of 2nd NS pivotal whole body clinical study for QRX003, CL-QRX003-002 Quoin Pharmaceuticals (NASDAQ:QNRX) reported 2Q25 results today and ...

The US Food and Drug Administration (FDA) has lifted a pause in the use of Valneva’s chikungunya vaccine Ixchiq in older ...

The US Food and Drug Administration (FDA) recently announced the availability of the first-ever centralized database of Complete Response ...

The FDA had halted use in older adults while it investigated reports of side effects. The vaccine’s label now carries new ...

MetrioPharm’s lead compound, MP1032, has received ODD from the European Medicines Agency (EMA) for treating DMD in children.

Vonaprument Selected by EMA as One of ~20 PRIME Development Programs in the Pilot Vonaprument Has the Potential to Be the First Treatment Approved in Europe and the U.S. for Dry AMD with Geographic ...

Hemispherian's GLIX1 gains FDA approval for glioblastoma trials, promising a novel therapy targeting DNA repair in tumor ...

Discover Curis, Inc.'s Q2 2025 earnings insights! Learn about emavusertib's progress, upcoming studies, milestones, and financial outlook.

Houston Center Cleared to Commence Commercial Sales of Normal Source PlasmaState of the Art Facility has Annual Collection ...

Discover key insights from Cytokinetics' Q2 2025 earnings call, including aficamten’s regulatory progress, launch plans, clinical milestones, and ...

Certara, Inc., a global leader in biosimulation, announced that the European Medicines Agency (EMA) has formally qualified the Simcyp Simulator for use in regulatory submissions across the EU. Certara ...